Obligations, precautions and pending issues in regulatory development for radiopharmaceuticals in Brazil
Radiopharmaceuticals are compounds that have a radionuclide and may be gamma-radiation emitter (γ) or positrons emitter (β+), linked to a molecule with specific diagnostic and therapeutic purposes. The progress in the use of radiopharmaceuticals has culminated to a sector in common with other types...
Main Authors: | Maryelle Moreira Lima Gamboa, Heveline Rayane Moura Roesch, Vanessa Pinheiro Amaral Lemos, Bruna Oliveira Rocha, Ralph Santos-Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2014-04-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000200285&lng=en&tlng=en |
Similar Items
-
4th International Seminar and 4th National Workshop on "Use and Development of Health-Related Industrial Isotope Products". Scientific report
by: Luis Ducat Pagés
Published: (2012-07-01) -
Radiopharmaceuticals in immunoscintigraphy and radioimmunotherapy
by: René Leyva Montaña
Published: (2012-07-01) -
Radiopharmaceutical market. Cuban scenario
by: Jorge Cruz Arencibia, et al.
Published: (2017-06-01) -
Avaliação do Controle de Qualidade de Radiofármacos em Serviço de Medicina Nuclear
by: Tavares Lopes Almeida, et al.
Published: (2015-05-01) -
Good practice in the production of radiopharmaceuticals
by: Jorge Cruz Arencibia
Published: (2012-07-01)